IGF2 and neoplasm: The occurrence of hypoglycemia in dogs with hepatic neoplasia is suggested to be secondary to the increased generation of insulin-like growth factor 2 (IGF-2), a normal product of hepatic metabolism that may be secreted in excess with increased tissue (tumor) volume.